Manufacturing Chemist Manufacturing Chemist
  • Home
  • Ingredients
  • Analysis
  • Manufacturing
  • Finance
  • Events
  • Directory
  • Regulatory
  • Drug Delivery
  • Research & Development
  • Sustainability

Dr Reddys Laboratories

www.drreddys.com

8-2-337 Road No 3
Banjara Hills
Hyderabad
500 034
India

+91 40 23731946

Activities

Manufacturing | Ingredients | Research & Development | Pharmaceutical

Related Companies

  • Romaco Holding GmbH
  • Titan Enterprises
  • Icrom SRL
  • TrakCel
  • Huber
  • Nanoform
  • GEA Pharma and Healthcare
  • Starlab
  • Adare Pharma Solutions
  • Beamex
  • Burkert Fluid Control Systems
  • Envair Technology
  • Biopharma Group
  • Asynt
  • PCI Pharma Services
  • Watson Marlow Fluid Technology Solutions
  • Solvias
  • Labtex
  • Piramal Pharma Solutions
  • LB Bohle

Related Content

Dr. Reddy’s Hyderabad factory joins Global Lighthouse Network
Dr. Reddy’s Hyderabad factory joins Global Lighthouse Network
Manufacturing Chemist Live: Day One Review
Manufacturing Chemist Live: Day One Review
Big names announced for leading Pharma and Cleanroom conference
Big names announced for leading Pharma and Cleanroom conference
Several large Indian pharma companies under US FDA scrutiny
Several large Indian pharma companies under US FDA scrutiny
Dr. Reddy's forms partnership with CutisPharma
Dr. Reddy's forms partnership with CutisPharma
Rising sun: generic consumption accelerating in Japan
Rising sun: generic consumption accelerating in Japan
Dr. Reddy’s and TR-Pharm announce strategic collaboration in Turkey
Dr. Reddy’s and TR-Pharm announce strategic collaboration in Turkey
Indian generic manufacturers aim to enter the Japanese market
Indian generic manufacturers aim to enter the Japanese market
Dr. Reddy’s receives warning letter from US FDA relating to three plants in India
Dr. Reddy’s receives warning letter from US FDA relating to three plants in India
Dr. Reddy’s to distribute three Amgen  medicines in India
Dr. Reddy’s to distribute three Amgen medicines in India
Dr Reddy’s raises its R&D spending
Dr Reddy’s raises its R&D spending
Dr Reddy’s to buy allergies and respiratory franchises in India from UCB for €118m
Dr Reddy’s to buy allergies and respiratory franchises in India from UCB for €118m
Dr. Reddy’s CPS creates new Centre of Excellence for formulation development services
Dr. Reddy’s CPS creates new Centre of Excellence for formulation development services
Operating margins expected to grow by 28% year-on-year for Indian pharma firms
Operating margins expected to grow by 28% year-on-year for Indian pharma firms
Syntheses that cut costs and boost yields
Syntheses that cut costs and boost yields
  • Advertise Subscribe
  • Terms & Conditions
  • Privacy Policy
  • Contact us at info@hpcimedia.com
Twitter LinkedIn RSS newsfeed
© HPCi Media Limited | Registered in England No. 6716035 | VAT GB 939828072 | a Claverley Group company